Let's talk medical research

On June 24, Melanoma Research Alliance’s (MRA) Chief Science Officer Marc Hurlbert and Director of Communications Cody Barnett joined Antidote's Head of Partnerships Lindsey Wahlstrom-Edwards in a webinar to discuss what matters most to melanoma patients when it comes to participating in clinical trials. The conversation, informed by a 2018 study of 444 melanoma patients and survivors, provided ...

With the rapid spread of COVID-19, sponsors, sites, CROs, and patients have had to adapt to our new virtual reality. There are many webinars and podcasts available, and we know it can be hard to choose what to tune in to. What follows is a list of webinars and podcasts that thoughtfully break down the changing nature of clinical trials in light of the COVID-19 pandemic and look at the state of ...

More than 80,000 people in the US will be diagnosed with bladder cancer this year. Treatment options have come a long way, and now include surgery, radiation, and chemotherapy — but many come with less than desirable side effects, and bladder cancer may recur. Research in this area is critical. 

Antidote takes pride in connecting people with medical research opportunities. But what motivates patients to participate in a clinical trial? We asked 4,000 volunteers and caregivers to help us understand their motivations so we can find better ways to engage patients in research. Here are some of the top reasons why patients volunteer for research.

We recently announced a collaboration with Ben’s Friends, a network of online communities for people impacted by rare disease, and MyRareData, an organization that facilitates fundraising for advocacy groups through data, to bring information about clinical trials to the rare disease community. 

With what we’re learning from the COVID-19 pandemic, can we create a permanent solution to keep the patient at the heart of clinical research? Last week a panel of experts, including our CEO, Laurent Schockmel, teamed up for an Ogilvy Consulting webinar, during which they discussed key industry considerations when it comes to putting patient centricity into action. 

Biliary tract cancer (BTC) is a rare form of cancer that develops in the bile duct system, which connects the liver, gallbladder, and small intestine, moving bile to the small intestine. There are three types of biliary tract cancer: Intrahepatic cholangiocarcinoma (ICC, or bile duct cancer), extrahepatic cholangiocarcinoma, and gallbladder cancer. While this form of cancer is particularly tough ...

The best clinical research blogs don’t just cover the latest news in the industry – they also take an informed position on how we can improve the research process. We count on the twelve blogs below for information that’s both useful for clinical research professionals, and makes us think, too. Follow them on social media or subscribe to their newsletters or blog feeds to make sure you’re always ...

An interview with Lindsey Wahlstrom-Edwards, Head of Partnerships at Antidote

In 2018, Antidote worked with SCORR Marketing and eight leading health organizations, including the Melanoma Research Alliance (MRA), to survey 4,000 patients about clinical research. About 10% of the total respondents self-identified as having melanoma.